Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM6ZXAX)

Drug Name

AVR-RD-02 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Gaucher disease	5C56.0Y	Phase 2/3	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Lysosomal acid glucosylceramidase (GBA1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PR001	DMQWR4N	Gaucher disease	5C56.0Y	Phase 1/2	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Lysosomal acid glucosylceramidase (GBA1)	TTCYHJ4	GBA1_HUMAN	Not Available	[1]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT05815004) Guard3: An Open-label, Parallel-arm, Randomized, Controlled, Phase 2/Phase 3 Study Evaluating the Efficacy and Safety of Autologous HSC Gene Therapy, AVR-RD-02, Compared to ERT for Gaucher Disease Type 3 in Participants Aged 2 to 25. U.S.National Institutes of Health.
2	Gene Therapy for Parkinson's Disease Associated with GBA1 Mutations. J Parkinsons Dis. 2021;11(s2):S183-S188.